UV Infection Control Devices Market

Market Overview

The global UV infection control devices market size was valued at USD 5.03 billion in 2022. It is estimated to reach USD 14.53 billion by 2031, growing at a CAGR of 12.50% during the forecast period (2023–2031). Factors such as increasing prevalence of hospital-acquired infections (HAI) and rising adoption of technologically advanced UV, significantly drives the UV infection control devices market demand by 2031.

UV infection control devices (ICDs) are used in operating rooms as well as to sterilize, cleanse, and disinfect various products using UV light. UV infection control devices are used in hospitals and other healthcare facilities to eliminate bacteria, viruses, and other infection-causing pathogens. This action is taken to prevent the proliferation of diseases. In hospitals and clinics, these devices eradicate infectious diseases such as Staphylococcus aureus and Pseudomonas aeruginosa. UV water treatment is widely recognized as a safer and more cost-effective solution for industrial applications.

UV disinfection equipment finds its way into a wide variety of industries, from the purification of drinking water in individual homes to the disinfection of an entire city's water supply to the treatment of wastewater in industrial settings. Furthermore, UV disinfection systems are gaining popularity as a safe and efficient replacements for traditional chemical water disinfection methods like chlorination and ozonation. It also offers benefits like quicker response times, simpler installation and maintenance, and lower capital and operating costs. 

Highlights

• Mobile dominates the product type segment.
• Hospitals dominate the end-user segment.
• North America is the highest shareholder in the global market.

Market Dynamics

Global UV Infection Control Devices Market Drivers

Increasing Prevalence of Hospital-Acquired Infections (HAI)

Infections that patients contract in a healthcare setting, such as a hospital, emergency room, outpatient clinic, long-term care facility, doctor's office, or community health center, are called "healthcare-associated infections." The U.S. Department of Health and Human Services estimates that nearly 1 million HAIs manifest in the nation's healthcare system yearly. Therefore, it is vital to decontaminate patient rooms, which is done by cleaning and disinfecting using several disinfectant methods such as chlorination, chlorine dioxide, chloramines, ozone, and UV radiation. Nevertheless, UV light is the primary technique for comprehensive infection management and prevention. Pathogen transmission in the healthcare setting is decreased and prevented with the help of UV infection control equipment. According to WHO research, ultraviolet disinfection equipment can eliminate up to 98% of infections in the operating room. Therefore, the abovementioned factors contribute to the market's expansion.

Rising Adoption of Technologically Advanced UV

Since bacteria's cell walls are the main target of this kind of injury, UV disinfection primarily harms them. The host organism has a higher level of defense once the integrity of the cell wall has been compromised because it makes future cell division more challenging. The UV infection control system has a greater adoption rate than conventional chemical disinfection systems. This is likely because it is easier to install and has a much smaller detrimental effect on the environment nearby.

Global UV Infection Control Devices Market Restraint

High Cost of UV Infection Control Devices

UV disinfection equipment is in high demand, but the exorbitant cost of such instruments prevents widespread adoption. This is the main hindrance to the market's expansion. Significant financial investments are needed for these items to feature cutting-edge technology and design advancements and remain competitive. Businesses must make these investments to maintain their performance level at the current level compared to our rivals. Depending on the size of the devices, the technology they employ, and the tasks they are meant to do, the costs of UV infection control systems that are permanently installed may differ dramatically.

Global UV Infection Control Devices Market Opportunities

High Growth Prospects in Emerging Markets

Emerging markets in Asia-Pacific and LAMEA would have higher growth prospects during the forecast period. It has been noted that among these developing nations, Brazil, Japan, India, and China have advanced disinfection techniques, grown more aware of their healthcare needs, and made an effort to strengthen their healthcare infrastructure. It is common knowledge that overpopulated nations like China and India have sizable elderly populations.

Additionally, it has been noted that hospital-acquired diseases contribute to increased fatalities in India. It is projected that these nations' stronger economies will favorably impact the development of this industry. The governments in these regions have also increased healthcare spending, which provides market participants with a tremendous opportunity to conduct R&D on technologically cutting-edge UV infection control equipment.

Regional Analysis

North America Dominates the Global Market

Based on region, the global UV infection control devices market share is bifurcated into North America, Europe, Asia-Pacific, and LAMEA.

North America is the most significant global UV infection control devices market shareholder and is estimated to exhibit a CAGR of 5.61% over the forecast period. The Centers for Disease Control (CDC) believes that 1.7 million infections in the United States occur yearly due to HAIs. As a result, the demand for UV infection control equipment has increased dramatically due to the sharp increase in HAI incidence. In addition, the increase in the prevalence of chronic illnesses, including cancer, hepatitis, and others that require surgical treatment and necessitate long hospital stays, are additional factors driving market expansion. This is because the length of hospital stay and risk of HAI acquisition are directly correlated.

Additionally, factors like the increase in R&D for introducing new medications for numerous infectious diseases are another driver that boosts the market growth. The market for UV infection control devices in the area is also growing due to the majority of major players' presence there. Furthermore, the presence of major players makes it simple for people to access these gadgets in the area, further accelerating the market's expansion.

Asia-Pacific is predicted to exhibit a CAGR of 8.1% over the forecast period. The countries in Asia-Pacific are densely populated. As a result, the region has the potential to supply a sizable patient pool, which is expected to encourage the growth of the Asia-Pacific market. In addition, the market offers significant potential for leading players, and Asia-Pacific experiences the quickest growth over the projection period. Due to rising disposable incomes, better health standards, and technological breakthroughs that have allowed for the creation of new UV infection control systems, the industry is expanding significantly. The rising prevalence of HAIs also contributes significantly to the growing demand for UV infection control devices.

In Europe, the increased prevalence of hospital-acquired infections and awareness of UV infection control devices are two additional reasons supporting the market expansion for these devices in the region. For instance, the House of Commons Library estimates that 300,000 patients in England annually contract an HAI due to receiving care from the National Health Services (NHS). As a result, the demand for UV infection control equipment increases. Another factor driving the growth of the region's market is the presence of prominent competitors. For instance, STERIS plc, Bioquell plc, and other major companies are active in the region's UV infection control devices industry. As a result, UV infection control devices are more readily available in the area, which helps the industry flourish. Increased usage awareness among end users, such as hospitals and clinics, is also a significant factor fueling the market's expansion.

In LAMEA, the market is still in its infancy due to low purchasing power, a lack of state-of-the-art medical facilities, insufficient health spending, and insufficient health coverage. In Brazil, the healthcare system is divided into three parts: a sizable public portion, a tiny paid health insurance portion, and a third small private portion where patients are responsible for paying out-of-pocket for medical care. Therefore, this prevents the development of UV infection control devices in this area.

LAMEA is a rising market since healthcare spending is expected to rise over the forecast period, offering industry participants lucrative growth prospects. A significant element in the market's expansion in this area is the high prevalence of HAIs. Due to economic reforms that raised living standards and opened up prospects for the research and healthcare industries, this area has experienced the strongest economic growth over the previous 20 years. These elements are predicted to fuel the market growth for UV infection control devices during the forecast period.

Segmental Analysis

The global UV Infection Control Devices Market is bifurcated into product type and end-user.

Based on the product type, the global market is bifurcated into mobile, stationery, and others.

The mobile segment dominates the global market and is projected to exhibit a CAGR of 7.31% over the forecast period. The electromagnetic spectrum, which ranges from the short wavelength to the X-ray region, is where ultraviolet photons are classified. Additionally, these rays are employed in various medical facilities, including hospitals, clinics, laboratories, and others, to eradicate infectious organisms. Therefore, these gadgets are used when a medical facility has been manually cleaned. In addition, UV infection control devices also release this radiation to eliminate harmful microorganisms, including viruses and bacteria. The devices emit light with a wavelength range of 100 to 280 nanometers (nm), which reaches its maximum germicidal potency at 253.7 nm.

Mobile UV infection control systems are conveniently transportable and moveable from one location to another. The devices also include grips on all sides that make it easier to transport them from one place to another. The global increase in the prevalence of hospital-acquired infections, which has increased the need for these devices, is a major reason for the expansion of mobile-type UV infection control systems. The advantages of using portable UV infection control devices are another aspect that contributes to the market's expansion. For instance, whereas other disinfection chemicals prevent the spread of infectious diseases, these devices destroy infectious diseases to eradicate them.

Based on end-user, the global market is divided into hospitals, clients, and others.

The hospital segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 6.8% over the forecast period. Hospitals require admitting patients so that staff members can care for them while they are there as part of the hospital's routine operations. Medical facilities are another name for hospitals. The care and treatment described in this article are only given to those accepted into the facilities. Hospitals also provide care for a wide range of patients, including those who are ill or injured and need immediate medical attention, such as surgery, and those who fit into other categories.

In addition, there has been a noticeable increase in facilities using ultraviolet (UV) disinfection techniques in recent years. These tools eliminate infectious bacteria that may result in fatal and life-threatening hospital-acquired diseases. Further, there has been an increase in the use of these devices due to a greater understanding of the advantages associated with their use. This is one of the factors contributing to the increase in the use of these gadgets. As a result, there has been an overall increase in the number of users of the gadgets.

Recent Developments

• April 2022- Evoqua Water Technologies (NYSE: AQUA), a leader in mission-critical water treatment solutions, closed the purchase of Mar Cor Purification and Cantel Medical, subsidiaries of STERIS Plc, renal business today. North America's top medical water, commercial, and industrial solutions provider is Mar Cor. Mar Cor has extensive experience designing, installing, and maintaining high-purity water treatment systems. Evoqua will be able to supply proven healthcare water solutions in North America with this acquisition.
• January 2022- Xylem and Isle Utilities, a water consultant, developed the "Trial Reservoir" to scale and fund breakthrough water technology. It funds pilot initiatives for water technology developers that reduce water system carbon emissions. With Xylem sponsors an innovative new finance model for water utilities to install potential new technologies through this relationship.